VECTORY
VectorY is a fully integrated gene therapy company specializing in the development of novel therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a particular emphasis on muscle diseases. It combines the therapeutic potential of antibodies and gene therapy to create long-term therapeutic solutions for large disease areas with significant unmet medical need. VectorY was founded in the Amsterdam Science Park in August 2020.
VECTORY
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.vectorytx.com
Total Employee:
51+
Status:
Active
Total Funding:
160 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API Google Tag Manager Google Analytics Content Delivery Network Global Site Tag Google Analytics 4 Pound Sterling
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Pathios Therapeutics
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series A - VectorY
ALS Investment Fund
ALS Investment Fund investment in Series A - VectorY
Insight Partners
Insight Partners investment in Series A - VectorY
EQT Life Sciences
EQT Life Sciences investment in Series A - VectorY
MRL Ventures Fund
MRL Ventures Fund investment in Series A - VectorY
BioGeneration Ventures
BioGeneration Ventures investment in Series A - VectorY
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Seed Round - VectorY
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - VectorY
Benhamou Global Ventures
Benhamou Global Ventures investment in Seed Round - VectorY
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-08 | VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team |
Official Site Inspections
http://www.vectorytx.com Semrush global rank: 4.05 M Semrush visits lastest month: 2.61 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "VectorY"
VectorY Therapeutics
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science and technologies.See details»
Treating neurodegeneration – About VectorY Therapeutics — …
Assembling a new gene therapy company to develop …
Aug 17, 2021 · VectorY is an Amsterdam based gene therapy company specialising in the development of vectorized antibodies to treat diseases of high unmet medical need, with a specific focus on muscle and neuromuscular …See details»
VectorY - Crunchbase Company Profile & Funding
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.See details»
VectorY - LinkedIn
Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized...See details»
VectorY Therapeutics - PitchBook
Developer of a medical platform designed to bring novel therapies to patients worldwide.See details»
VectorY - EQT Group
Oct 31, 2024 · vectorytx.com. Latest news. 18 November 2024 EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics; 18 November 2024 EQT Exeter to Acquire …See details»
VectorY and Annogen Announce Research Collaboration for the …
Jan 19, 2023 · VectorY is on a mission to provide people with neurodegenerative diseases a longer, better life by creating transformative vectorized antibody treatments. Our platform …See details»
VectoryTx Therapeutics - Products, Competitors, Financials, …
VectoryTx Therapeutics is a biotech company with a focus on neurodegenerative diseases. The company develops vectorized antibodies, which are potentially disease-modifying treatments …See details»
VectorY strengthens leadership with appointments of …
Jun 15, 2021 · VectorY combines the therapeutic potential of antibodies, RNA and gene therapy to develop long-lasting therapeutic solutions for muscular and neurodegenerative diseases with high unmet medical need.See details»
VectorY Therapeutics - Overview, News & Similar companies
Jan 18, 2024 · View VectorY Therapeutics (www.vectorytx.com) location in North Holland, Netherlands , revenue, industry and description. Find related and similar companies as well as …See details»
VectorY Announces Preclinical Data on TDP-43 and ... - Business …
May 18, 2022 · VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for neurodegenerative and -muscular diseases with …See details»
VectoryTx - Raised $176M Funding from 8 investors - Tracxn
Nov 13, 2024 · VectoryTx has raised a total funding of $176M over 2 rounds from 8 investors. Investors include EQT, Forbion and 6 others. Their latest funding round was of $138M on Nov …See details»
VectorY - VentureRadar
"VectorY Therapeutics is a biotech company founded in 2020 with a mission to develop vectorized antibody treatments for people with neurodegenerative diseases, enabling longer, better lives. …See details»
News – Updated corporate identity — VectoryTx
Jan 10, 2023 · We are excited to start the year with a fresh look that better represents VectorY and our innovative, dynamic and fun culture. What’s in a name? Did you know the name …See details»
VectoryTx - Company Profile - Tracxn
Oct 11, 2024 · VectoryTx - Developer of therapeutics for neurodegenerative and muscular disorder. Raised a total funding of $176M over 2 rounds from 8 investors. Founded by Pavlina …See details»
VectorY Company Profile - Office Locations, Competitors ... - Craft
VectorY is a provider of therapeutic solutions. It has expertise in the design, construction, manufacturing, and process development of operations for biopharmaceutical facilities …See details»
Efficient intracellular therapeutic antibodies - VectoryTx
Engineered AAV vectors optimized for effective and wide-spread CNS delivery. Stable, robust, and scalable AAV manufacturing for high yields and low cost. Our platform utilizes cutting …See details»
VectorY Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for VectorY. See VectorY company profile and funding data.See details»
Press releases and news - VectoryTx
Jan 18, 2024 · VectorY is participating in a large cureQ consortium named “Predict, Delay & Cure polyglutamine (Q) caused neurodegeneration”. Read the latest press releases and other news …See details»